Immunology
Perspectives
Three wild technologies about to change health care
Now, in the 23rd year of the 21st century, you might not believe what we’ll be capable of next.
Commentary
A new (old) drug joins the COVID fray, and guess what? It works
Part of the reason the monoclonals have failed lately is because of their specificity.
From the Journals
Maternal COVID-19 vaccine curbs infant infection
Maternal mRNA COVID-19 vaccination during pregnancy was less effective in protecting infants against omicron.
Feature
More data back Guillain-Barré risk with Janssen COVID shot
Observed GBS cases after the Janssen shot were 2 to 3 times greater than expected, based on background rates within 21 and 42 days of vaccination...
Feature
Inflammation and immunity troubles top long-COVID suspect list
“I think that it’s a much more complex picture than just inflammation, or just autoimmunity, or just immune dysregulation,” says expert.
Feature
Long COVID affecting more than one-third of college students, faculty
A new study is unique for evaluating mostly healthy, young adults and for its rare look at long COVID in a university community.
News
FDA wants annual COVID boosters, just like annual flu shots
The booster’s formulation would be selected in June targeting the most threatening COVID-19 strains.
Feature
Highly anticipated HIV vaccine fails in large trial
The vaccine had been in development since 2019 and was given to 3,900 study participants through October 2022.
From the Journals
Scientists use mRNA technology for universal flu vaccine
Two years ago marked a significant moment for messenger RNA (mRNA) technology.
Feature
COVID booster shot poll: People ‘don’t think they need one’
A new poll shows why so few people are willing to get the latest COVID booster.
Feature
As COVID treatments dwindle, are new ones waiting in the wings?
Bebtelovimab couldn’t neutralize the Omicron subvariants BQ.1 and BQ.1.1.